CHARLES CITY, Iowa --- Cambrex Charles City Inc. announced a $19 million construction project that could lead to 45 to 60 new jobs over the next three years.
The expansion project will increase the plant’s ability to manufacture active pharmaceutical ingredients (APIs) and advanced intermediates for the pharmaceutical industry, according to a news release from the company.
“We are very pleased that Cambrex is experiencing this level of growth within a very competitive industry,” said Joe Nettleton, vice president of operations and Charles City site director.
“The expansion of our Charles City facility will position us well to bring more pharmaceutical products and greater and more diverse quantities of therapeutics to the marketplace and the patients they serve.”
Tim Fox, executive director of the Charles City Area Development Corp., said the economic impact of the project is extremely positive.
“This will be the third large project where the area development corporation has collaborated with Cambrex Charles City Inc.,” he said. “It’s an exciting capital investment in job creation by a successful global company that will benefit the residents of Floyd County and all of North Iowa.”
Cambrex Charles City Inc., which employs 215 people, develops and manufactures active pharmaceutical ingredients and bulk pharmaceutical intermediates that are used to produce other drugs.
The Charles City facility does research and development and provides manufacturing and services to develop branded and generic medicines.